Lung cancer treatment is associated with Lambert-Eaton Myasthenic Syndrome (LEMS), a condition that causes muscle weakness. There are various approaches to managing LEMS, including the use of medications such as efgartigimod and amifampridine. The relationship between LEMS and cancer is still being studied, with research suggesting that LEMS may be linked to several types of cancer, not just small cell lung cancer.